InvestorsHub Logo
Followers 646
Posts 144549
Boards Moderated 1
Alias Born 05/19/2007

Re: None

Wednesday, 09/13/2017 2:25:55 PM

Wednesday, September 13, 2017 2:25:55 PM

Post# of 2804248
$TXTM's Phytofare® has been clinically proven in human studies to provide ten times greater bioavailability, which is the ability of the body to absorb the nutrients, over generic plant extracts. The first product brought to market, Phytofare® catechin complex, is derived from green tea and contains all eight catechins in a highly absorbable biocompatible structure. Where the parent company, Plandaí Biotechnology, focuses on selling Phytofare® as an ingredient to manufacturers in the nutraceutical industry, Plandaí SA will target the pharmaceutical market with a finished product. Learn more at: http://www.protextm.co

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.